Nonsense-mediated mRNA decay (NMD) is an evolutionarily conserved mRNA surveillance system that degrades mRNA transcripts that harbour a premature translation-termination codon (PTC), thus reducing the synthesis of truncated proteins that would otherwise have deleterious effects. Although extensive research has identified a conserved repertoire of NMD factors, these studies have been performed with a restricted set of genes and gene constructs with relatively few exons. As a consequence, NMD mechanisms are poorly understood for genes with large 39 terminal exons, and the applicability of the current models to large multi-exon genes is not clear. In this Commentary, we present an overview of the current understanding of NMD and discuss how analysis of nonsense mutations in the collagen gene family has provided new mechanistic insights into this process. Although NMD of the collagen genes with numerous small exons is consistent with the widely accepted exon-junction complex (EJC)-dependent model, the degradation of Col10a1 transcripts with nonsense mutations cannot be explained by any of the current NMD models. Col10a1 NMD might represent a fail-safe mechanism for genes that have large 39 terminal exons. Defining the mechanistic complexity of NMD is important to allow us to understand the pathophysiology of the numerous genetic disorders caused by PTC mutations.
Introduction
Nonsense-mediated mRNA decay (NMD) is an evolutionarily conserved cellular surveillance and quality control process present in all eukaryotic cells. It functions to selectively target mRNA transcripts that harbour a premature translation-termination codon (PTC) for rapid degradation, thus reducing the synthesis of truncated proteins with potentially deleterious dominant-negative effects (for detailed reviews, see Behm-Ansmant and Izaurralde, 2006; Brogna and Wen, 2009; Chang et al., 2007; Huang and Wilkinson, 2012; Kervestin and Jacobson, 2012; Maquat, 2004) . PTCs are common, accounting for around a third of mutations in inherited genetic disorders (Holbrook et al., 2004; Kuzmiak and Maquat, 2006; Mendell and Dietz, 2001) . They arise when a single base change in the genomic DNA directly introduces a stop codon or indirectly from shifts in the translation reading frame that are caused by exon-skipping mutations or genomic insertions or deletions. PTCs can also arise from regulated or aberrant alternative splicing events that produce a PTC-containing mRNA (Cuccurese et al., 2005; Lareau et al., 2004; Lewis et al., 2003; Mitrovich and Anderson, 2000) . As well as its role in mutation surveillance and quality control, NMD is increasingly becoming implicated in the regulation of normal gene expression -the levels of as many as 10% of mRNAs coding for full-length proteins are altered when NMD is ablated (He et al., 2003; Mendell et al., 2004; Wang et al., 2011) . NMD is involved in regulating normal development (Hwang and Maquat, 2011) and, adding further complexity to this role, NMD itself can be developmentally regulated (Huang and Wilkinson, 2012) . Our focus in this Commentary is on NMD pathways for aberrant PTC-containing transcripts.
The crucial first steps in NMD are recognizing that a stop codon is premature, marking the PTC-containing mRNA transcript as aberrant and targeting it for degradation. Although this fundamental molecular recognition process has been the subject of much study and the core NMD components are conserved across species, the precise mechanisms of PTC identification vary between species, between cells and between mRNA transcripts (Chang et al., 2007; Huang and Wilkinson, 2012; Schweingruber et al., 2013) . In addition, the complexities of PTC recognition might have been underestimated because many of the studies that defined NMD mechanisms and underpin the current models of PTC recognition focussed on a limited number of genes or gene constructs, commonly triosephosphate isomerase (TPI) (Carter et al., 1996; Thermann et al., 1998; Zhang et al., 1998a) , T-cell receptor b (TCRB), b-globin (HBB) and phosphoglycerate kinase I (PGK1) (Amrani et al., 2004; Carter et al., 1996; Ishigaki et al., 2001; Ivanov et al., 2008; Le Hir et al., 2001; Silva et al., 2008; Thermann et al., 1998; Zhang et al., 1998a) . In this Commentary, we first discuss the four current models of how the NMD machinery discriminates between premature and normal terminations. This provides a background to our discussion of the examples of collagen NMD mutations, which add to our understanding of PTC recognition in multi-exon genes with many small exons. We then focus our discussion of collagen NMD on an intriguing example, that of Col10a1. PTCs in the last exon of this gene lead to NMD that does not depend on RNA splicing. These and other characteristics make Col10a1 NMD difficult to reconcile with current models of how PTCs are recognized and introduce additional complexity into our understanding of mammalian NMD pathways. We suggest that Col10a1 NMD might represent a fail-safe RNA decay pathway for many genes that have large 39 terminal exons.
Models of PTC recognition NMD was discovered in Saccharomyces cerevisiae when orotidine monophosphate decarboxylase (ura3) alleles containing nonsense mutations produced unexpectedly low concentrations of mRNA transcripts (Losson and Lacroute, 1979) . Up-frameshift 1 (UPF1) was the first gene shown to be necessary for NMD (Leeds et al., 1991) , and this was rapidly followed by the identification of UPF2 (Cui et al., 1995) and UPF3 (Leeds et al., 1992) as genes essential for NMD (see Box 1 for details of core NMD components). The first model of PTC recognition was based on studies showing that NMD of PGK1 mRNA was abolished when sequences known as downstream sequence elements (DSEs) were deleted, leading to the proposal that specific DSEs differentiated normal and premature stop codons (Hilleren and Parker, 1999; Peltz et al., 1993; RuizEchevarria et al., 1998) . In this yeast model, the DSEs bind factors, such as hnRNP protein (Hrp1), which then interact with Upf1 to initiate NMD (González et al., 2000) . The general applicability of the simple DSE model is compromised by the inability to define these putative specific DSEs more generally in NMD transcripts, and it has now been superseded by the faux 39UTR model (see below).
Faux 39UTR model
Studies in yeast led to the 'faux 39UTR model' of PTC recognition (Fig. 1A) . This model proposes that normal termination is defined by the interaction between eukaryotic release factor 3 (eRF3), a peptide release factor located on the terminating ribosome, and poly(A)-binding protein 1 (Pabp in yeast, PABPC1 in mammals) (Hoshino et al., 1999) . When the extended 39UTR that results from a PTC prevents this interaction, translation termination signals are recognized as premature and NMD-stimulating factors then associate with the ribosome and induce degradation of the mRNA transcript (Amrani et al., 2006) . In support of this model, an aberrant termination codon is not recognized as premature when Pabp is artificially tethered close to the PTC in the mRNA of yeast arginine permease (CAN1) (Amrani et al., 2004) . However, other experimental data challenge the proposal that Pabp is essential for PTC recognition in yeast. A green fluorescent protein reporter mRNA that contains a PTC and lacks a poly(A) tail is degraded by NMD in yeast, as is a PTC-containing yeast HIS3 mRNA engineered to lack a poly(A) tail (Meaux et al., 2008) . These mRNAs would not be expected to bind Pabp. Furthermore, yeast PGK1 mRNA containing a PTC is still subjected to NMD when expressed in yeast lacking Pabp (Meaux et al., 2008) . These data suggest that neither Pabp or a poly(A) tail are required for NMD in yeast. The faux 39UTR model is also challenged by experiments showing that PTCs close to the initiation codon at the 59 end of CYC1 mRNA elicit strong NMD (Yun and Sherman, 1995) . Eukaryotic mRNA transcripts adopt a closed loop conformation via the interaction of eukaryotic translation initiation factor 4 gamma 3 (eIF4G3) at the 59 end with Pabp at the 39 end (Amrani et al., 2008; Imataka et al., 1998; Le et al., 1997; Tarun and Sachs, 1996; Tarun et al., 1997; Wells et al., 1998) . In this conformation, stop codons close to the translation initiation codon would not be recognized as premature because eRF3 on a ribosome terminating translation would still be able to interact with Pabp ( Fig. 1A ) (Hoshino et al., 1999; Silva et al., 2008; Silva and Ramao, 2009; Yun and Sherman, 1995) .
Box 1. Core NMD machinery
Panel A of the figure shows the mRNA in the closed loop conformation ready for the pioneer round of translation. PABPC1 binds to the poly(A) tail located at the 39 end of mRNAs. PABPC1 interacts with eRF3 and this interaction defines a normal termination event. Cap binding complex (CBC), a heterodimer of CBP80 and CBP20, binds to the 7-methylguanosine cap at the 59 end of newly transcribed mRNA that has yet to undergo a first round of translation. eIF4E is a 7-methylguanosine (m 7 G)-capbinding protein and it replaces the CBC following the pioneer round of translation. Eukaryotic translation initiation factor 4G (eIF4G) has many protein binding partners including the CBC, eIF4E, and PABPC1. The interaction between eIF4G and CBC (during the pioneer round of translation) or the eIF4G (during subsequent rounds of translation) places eIF4G at the 59 end of the mRNA. The interaction of eIF4G with PABPC1 at the 39 end results in the mRNA adopting a closed-loop conformation. eRF3 and eRF1 are required to complete protein synthesis. They associate to form the translation termination complex, which binds to ribosomes when they encounter a stop codon and triggers release of the polypeptide chain from the ribosome.
Panel B of the figure shows the core EJC. This is a multi-protein complex that is deposited 20-24 nt upstream of exon-exon junctions during pre-mRNA splicing and remains bound to the mRNA until it is translated. There are four core EJC components: eukaryotic translation initiation factor 4A3 (eIF4A3), Barentsz (Btz, mammalian gene CASC3), mago nashi homolog (MAGOH), and Y14 (mammalian gene RBM8A). The core EJC can bind and release additional factors depending on the molecular and spatial context. UPF1, UPF2 and UPF3 are also essential NMD components. UPF1 is an RNA helicase and its phosphorylation is essential for its activity during NMD. UPF2 binds to UPF3, which in turn binds to the EJC by interacting with Y14. UPF1 and SMG1, associate with eRF1 and eRF3 to form the SURF complex. During a premature termination event SMG1 interacts with UPF2 and UPF3 on the EJC. SMG1 then phosphorylates UPF1, which triggers NMD. In mammalian cells, PTC recognition has been proposed to require a downstream marker, the exon-junction complex (EJC). The EJC is a multi-protein complex that is deposited onto mRNA 20-24 nucleotides (nt) upstream of exon-exon junctions during splicing; a recent study indicates that EJCs are deposited upstream of ,80% of exon-exon junctions in human mRNAs (Singh et al., 2012) . The core EJC contains four proteins, 
Exposed to n u c l e a s e s (A) The faux 39UTR model proposes that the distinction between a normal and premature termination codon depends on the distance between the terminating ribosome (rib.) and the poly(A) tail (AAA). Normal translation termination is characterized by the interaction of eRF3 with PABPC1. This interaction is indicated with a green arrow. Premature termination prevents the eRF3-PABPC1 interaction (red arrow with cross) by artificially increasing the length of the 39UTR and the physical distance between the two proteins. (B) In the EJCdependent model, differentiation between a normal and premature termination codon requires splicing-dependent deposition of a specific protein complex, the EJC (core EJC), 20 to 24 nt upstream of exon-exon junctions, and a pioneer round of translation. See Box 1 for details on EJC components. In normal translation termination, the translating ribosome traverses the entire length of the mRNA during the pioneer round of translation and displaces all the EJCs that it encounters. When it reaches the normal stop codon in the last exon, all EJCs have been displaced and the communication of eRF3 with PABPC1 (green arrow) signals normal termination. Premature translation termination is characterized by the presence of a core EJC downstream of the stop codon. This remaining EJC recruits the NMD effectors UPF2 and UPF3 and the SURF protein complex (SMG1, UPF1, and eRF1 and eRF3), and this EJC-SURF interaction (green arrow) leads to phosphorylation (P) of UPF1 by SMG1, which initiates degradation of the PTC-containing transcript.
(C) The unified model incorporates elements from both the EJC and faux 39UTR models and proposes that recognition of a premature stop codon involves competition between UPF1 in the SURF complex and eRF3 on the terminating ribosome for interaction with PABPC1. A normal termination event is characterized by the interaction of eRF3 with PABPC1 (green arrow). In a premature termination event eRF3 and PABPC1 are unable to bind (red arrow with cross) and interaction of UPF1 with PABPC1 is possible. In this model, the EJC is not absolutely required for PTC recognition but instead functions as an enhancer. (D) The ribosome release model proposes that early ribosome release caused by the presence of a PTC exposes the downstream unprotected mRNA to degradation by nucleases. Translationally competent ribosomes normally protect the mRNA from degradation as they traverse the transcript, but at a PTC it is proposed that the interaction of UPF1 with eIF3 stimulates ribosome release.
eukaryotic translation initiation factor 4A3 (eIF4A3), barentsz (Btz, also known as CASC3), Mago (MAGOH) and Y14 (also known as RNA-binding protein 8A, RBM8A) (Bono et al., 2006; Le Hir et al., 2001; Le Hir et al., 2000) . Newly synthesized mRNAs are bound at the 59 end by the cap-binding complex (CBC), a heterodimer of cap binding protein 80 (CBP80) and CBP20 (Maquat et al., 2010) , and during a 'pioneer round' of translation, it is proposed that the translating ribosome scans the entire length of the CBC-bound mRNA, displacing all EJCs from the transcript until it reaches the normal translation termination codon. Once this pioneer round of translation is complete, mRNA transcripts exchange the CBC for eIF4E and, because the eIF4E-bound mRNAs are no longer decorated with EJCs, they are not susceptible to NMD Lejeune et al., 2002) .
In the event that a ribosome terminates translation prematurely due to the presence of a PTC, EJCs downstream of the PTC will remain and recruit NMD effectors, forming functional NMD complexes and rapidly degrading the PTC-containing mRNA (Culbertson and Neeno-Eckwall, 2005; Ishigaki et al., 2001; Maquat, 2004) (Fig. 1B) .
The EJC provides a binding platform on which NMD effectors, such as UPF2 and UPF3, assemble (Kim et al., 2001; Le Hir et al., 2001) . The EJC interacts with another multi-protein complex, the SURF complex, composed of suppressor with morphogenetic effect on genitalia 1 (SMG1), UPF1, eRF1 and eRF3 (Kashima et al., 2006) . UPF1 is an essential NMD effector and the phosphorylation status of specific serine residues in UPF1 determines its activity (Kashima et al., 2006; Page et al., 1999; Pal et al., 2001; Unterholzner and Izaurralde, 2004) . UPF1 phosphorylation is mediated by SMG1, a kinase related to phosphoinositol 3-kinase (Grimson et al., 2004; Page et al., 1999; Pal et al., 2001; Yamashita et al., 2001) , following its interaction with UPF2 and UPF3 (Kashima et al., 2006) . Phosphorylated UPF1 then transiently associates with ribosome-bound eIF3, and this interaction is proposed to result in translational repression by inhibiting the eIF3-dependent conversion of the 40S-MettRNA i Met -mRNA complex to the translation competent 80S-Met-tRNA i Met -mRNA initiation complexes Woeller et al., 2008) . As a consequence of this translational repression, NMD-competent mRNAs are committed to rapid degradation, mediated by recruited decay factors. Upon successful NMD, UPF1 is dephosphorylated in order to take part in another round of mRNA surveillance and quality control. On the basis of the central role of UPF1 in NMD and these collective findings, the three UPF proteins are hypothesized to constitute the core NMD machinery and function to link premature translation termination to mRNA degradation (Conti and Izaurralde, 2005; Lejeune and Maquat, 2005; Singh et al., 2008) .
Although EJCs might provide a crucial downstream mark, only PTCs that are located more than 50-55 nt upstream of the most 39 exon-exon junction appear to be capable of eliciting NMD (Nagy and Maquat, 1998; Thermann et al., 1998) . This '50-55 nt rule' would suggest that NMD does not occur when PTCs are located within the 50-55 nt upstream of the most 39 exon-exon junction because the downstream EJC will be displaced by the terminating ribosome when they are in such close proximity. Consistent with a model of PTC recognition that depends on EJCs, PTCs that are located in the terminal exon of several experimentally tested genes also do not elicit NMD because there are no EJCs downstream of the mutant termination codons that could identify them as premature (Cheng et al., 1990; Sun et al., 2000) . The importance of the EJC in NMD was further emphasised in work that artificially tethered partner of Y14 and Mago (PYM; also known as WIBG) or RNA binding protein S1 (RNPS1), both non-core EJC components involved in NMD, to the 39UTR of b-globin transcripts, which resulted in the normal stop codon becoming NMD competent (Bono et al., 2004; Lykke-Andersen et al., 2001 ). Further, PTC-containing transcripts from the naturally intron-less mammalian genes melanocortin 4 receptor (MC4R), heat shock protein 70 (HSP70) and histone H4, which would not be expected to harbour EJCs, are all resistant to NMD (Brocke et al., 2002; Maquat and Li, 2001) . It is important to note that although the experimental data indicate the 50-55 nt rule applies to the most 39 exon-exon junctions (Carter et al., 1996; Cheng et al., 1994; Cheng et al., 1990; Daar and Maquat, 1988; Zhang et al., 1998a; Zhang et al., 1998b) , this rule is based on studies using a limited number of gene constructs, namely TPI, TCRB and HBB. How well the rule fits with NMD in the large collagen genes with numerous small exons has not been explored, and we address this later in this Commentary.
Although much experimental evidence lends support to an EJC-dependent model of PTC recognition as the predominant mammalian NMD pathway, there are also studies that question whether some of its steps need always be strictly adhered to. For example, the requirement for pre-mRNA splicing and EJC deposition was disputed when introns and EJCs were found to not be required for NMD in Drosophila melanogaster (Gatfield and Izaurralde, 2004) and Caenorhabditis elegans (Longman et al., 2007) . In addition, several studies have demonstrated that NMD is activated by TCRB and immunoglobulin (Ig)-m (IGHM) transcripts that harboured PTCs at less than 50 nt from the terminal exon-exon junction (Bühler et al., 2004; Carter et al., 1996; Wang et al., 2002) . In addition, when intron 6, the most 39 intron of TP1 is deleted, NMD of mRNAs that have PTCs in exon 6 still occurs, albeit less efficiently, suggesting that other sequences are also involved in PTC recognition and that the intron acts as an NMD enhancer (Cheng et al., 1994) . Subsequent studies have also shown that introns and EJCs are not essential for degradation of an IGHM mini-gene reporter (Bühler et al., 2006) . Intriguingly, evidence has emerged that supports a mechanism of NMD activation that relies on the distance between the termination event and the 39 end (similar to the faux 39UTR model) and requires PABPC1. For example, extending the length of the 39UTR in normal mammalian IGHM and D. melanogaster Alcohol dehydrogenase (Adh) transcripts leads to normal termination codons being recognized as premature and thus they are NMD competent (Behm-Ansmant et al., 2007; Bühler et al., 2006; Eberle et al., 2009; Eberle et al., 2008) . Tethering of PABPC1 near the PTCs of IGHM or Adh transcripts suppresses NMD, emphasising the importance of PABPC1 for normal translation termination (Behm-Ansmant et al., 2007; Eberle et al., 2008; Mangus et al., 2003) . By contrast, PABPC1 is not required for NMD in yeast (Meaux et al., 2008; Wen and Brogna, 2010) , perhaps pointing to mechanistic differences between yeast and higher organisms.
Unified model
A unified model has been recently proposed to reconcile aspects of the different models that have been suggested in lower organisms and mammals (Fig. 1C) (Amrani et al., 2006; Ivanov et al., 2008; Mühlemann, 2008; Silva et al., 2008; Singh et al., 2008 ). This unified model incorporates elements from the faux 39UTR and EJC-dependent models, and also takes into account the closed-loop mRNA structure mentioned above. It proposes that recognition of a translation termination codon as premature relies on UPF1 and PABPC1 competing for binding to ribosomebound eRF3 (Amrani et al., 2006; Ivanov et al., 2008; Parker and Song, 2004; Silva et al., 2008; Singh et al., 2008) . According to this model, a normal termination event is characterized by the interaction of eRF3 with PABPC1, whereas a premature termination event involves the binding of UPF1 to eRF3 (Fig. 1C) . The latter scenario occurs when a ribosome stalls at a PTC at a sufficient distance away from the poly(A) tail. The more upstream from the tail a PTC is located, the more likely it is that PABP is not positioned favourably to interact with eRF3, and thus that NMD is activated. In contrast to the EJC-dependent model, the unified model proposes that an EJC downstream of the PTC is not essential for NMD. Instead the downstream EJC functions as an NMD enhancer by positioning UPF2/UPF3 close to the terminating ribosome and facilitating phosphorylation of ribosome-bound UPF1 by SMG1 Mühlemann, 2008; Mühlemann et al., 2008; Nicholson et al., 2010 ). The unified model thus accounts for EJC-independent degradation of IGHM transcripts with PTCs (Bühler et al., 2006) while recognizing the importance of EJCs for efficient mammalian NMD.
Ribosome release model
More recently, another model of NMD, the 'ribosome release model', has been suggested (Brogna and Wen, 2009 ). Here, NMD has been proposed to be the consequence of early ribosome release, which leaves the region of mRNA that is normally protected by the translating ribosomes exposed and susceptible to nuclease attack (Fig. 1D) . Unlike in other models, PTC recognition in this model does not depend on the nature of the 39UTR or the proximity to PABPC1. This model incorporates data indicating that phosphorylated UPF1 interacts with eIF3 to stimulate ribosome release from the mutant mRNA resulting in exposure of the mRNA to nucleases. Furthermore, the interaction of phosphorylated UPF1 and eIF3 inhibits the formation of the translation-competent 80S ribosome from 40S and 60S subunits, resulting in translation repression, which might be a key step in recruiting mRNA decay factors. Although this model incorporates the current knowledge of NMD it remains speculative and has not been experimentally tested.
That none of the current experimentally tested models completely encapsulates all known examples of PTC recognition highlights our lack of understanding of the full mechanistic complexities of NMD. In this regard, it is important to recognize that the studies that elucidated important aspects of PTC recognition and identified the machinery involved in each model were often performed in different organisms and using only a restricted set of genes. Many studies used genes or reporter constructs that were short and possessed few exons, chosen to facilitate experimental manipulation and analysis, such as the HBB, TPI and TCRB gene constructs. As a result, it is possible that the proposed mechanisms might be applicable to only a limited group of genes that are similar in structure. For genes with different sizes and complexities that do not belong to this group, it is plausible that additional cis-and trans-acting factors, not previously detected, might function in NMD. These factors could bind to specific sequences or features that are present only in larger and more complex genes where they might function in increasing the specificity and identification of NMD targets, thus providing appropriate RNA surveillance and quality control. In this context, it is perhaps no surprise that some genes, including at least one in the collagen family, do not readily fit into the proposed models as discussed below.
Collagen NMD
The collagen gene family encodes 42 collagen protein subunits (a-chains) that assemble into specific homo-or hetero-trimers and form the major structural networks of the vertebrate body (Chu and Prockop, 2002; Kadler et al., 2007) . The common feature that all members share is the presence of repetitive Gly-X-Y amino acid motifs (where X and Y are frequently proline and hydroxyproline, respectively) that are crucial for folding and formation of the collagen triple helix. This essential motif is often segregated across multiple exons. In the case of the more abundant fibrillar collagens (collagen types I, II and III), this motif is the predominant coding sequence and is distributed over 42 of the 51 to 54 exons. Importantly, exons coding for the triple helix are relatively small; commonly 45 nt (4 out of 42 exons), 54 nt (23 out of 42 exons) or 108 nt (8 out of 42 exons). The three genes encoding collagen VI, COL6A1, COL6A2 and COL6A3, also have numerous exons, 35, 28 and 44, respectively. In each gene, 19 exons code for the triple helix and 30 of the total 53 exons contain 54 or fewer bases.
Because of the fundamental physiological importance of collagen proteins, mutations affecting collagen genes cause a range of inherited connective tissue disorders (Myllyharju and Kivirikko, 2004) . Hundreds of collagen mutations have been identified and many introduce premature stop codons. Attempts to understand the molecular pathology of these collagenopathies have often concluded that PTC mutations might lead to NMD and thus result in collagen haploinsufficiency (Lamandé et al., 1998; Willing et al., 1994; Willing et al., 1996) . Despite the expected impact of PTC mutations, it is surprising that relatively few aberrant PTC-containing collagen mRNA transcripts have been directly studied. This is of particular importance, because although there is strong experimental evidence indicating that the 50-55 nt rule applies only to the most 39 exon-exon junction, recently this rule has been described in terms that suggest that it applies to all exon-exon boundaries (Hwang and Maquat, 2011; Isken and Maquat, 2007) . As many exons in the collagen genes are small and many PTCs are therefore less than 55 nt away from the downstream exon-exon boundary this has led to confusion about the fate of collagen transcripts with PTCs. In the discussion below, we consider the collagen PTC mutations for which NMD has been experimentally tested to determine what collagen mutations tell us about current NMD models.
COL1A1, COL6A1 and COL6A2 PTCs point to EJC-dependent NMD
Osteogenesis imperfecta (OMIM 166240), also called 'brittle bone disease', commonly results from mutations in the genes encoding type I collagen. The dominantly inherited milder form of osteogenesis imperfecta (osteogenesis imperfecta type I) can be caused by PTC mutations in the collagen a1(I) chain gene COL1A1 that lead to NMD-mediated mutant-allele-specific reductions in COL1A1 mRNA (Redford-Badwal et al., 1996; Slayton et al., 2000; Stover et al., 1993; Willing et al., 1994; Willing et al., 1996; Willing et al., 1992) . The position of its PTCs relative to the downstream exon-exon junctions provides insights into the applicability of the 50-55 nt rule to the immediately downstream exon-exon junction. In five out of 16 PTCs for which detailed studies have determined NMD competency, PTCs occur more than 50-55 nt upstream of a splice junction and result in NMD as predicted by the EJCdependent model (Stover et al., 1993; Willing et al., 1994) . In one case, the introduced PTC that triggers NMD is 54 nt away from the splice junction and is thus uninformative with regard to the applicability of the 50-55 nt rule to all exons (Willing et al., 1996) . Importantly, ten PTCs that are located less than 50 nt upstream of the next exon-exon junction result in NMD (Slayton et al., 2000; Willing et al., 1994; Willing et al., 1996; Willing et al., 1992) (Table 1 ), demonstrating that for COL1A1 stop codons are recognized as premature as long as there is at least one downstream EJC remaining on the mRNA after translation termination. Although none of these ten PTCs are in the penultimate 39 exon, these data are consistent with the EJCdependent model, which posits that stop codons more than 50-55 nt upstream of the most 39 exon-exon boundary are recognized as premature. The EJC-dependent model also predicts that PTCs in the most 39 exon do not trigger NMD, and this is supported by a frameshift mutation observed in a patient with the severe lethal form of osteogenesis imperfecta (osteogenesis imperfecta type II). In this example, the mutation resulted in a PTC in the last COL1A1 exon, 37 codons away from the normal stop codon, that does not trigger NMD (Bateman et al., 1989) .
PTCs in the genes encoding collagen type VI a1(VI) and a2(VI) chains, COL6A1 and COL6A2, are found in Bethlem myopathy (OMIM 158810) and Ullrich congenital muscular dystrophy (OMIM 254090) patients and provide further examples of NMD occurring when the PTC is close to the next downstream exon-exon junction. There are five experimentally assessed examples of PTCs that are positioned less than 50 nt upstream of the next exon and that trigger NMD of COL6A1 and COL6A2 mRNA (Camacho Vanegas et al., 2001; Giusti et al., 2005; Lamandé et al., 1998; Peat et al., 2007) (Table 1) . However, COL6A2 mRNA with a PTC in the penultimate exon, four nucleotides upstream from the most 39 exon-exon boundary, is stable (Merlini et al., 2008) , indicating that the 50-55 nt rule does apply to the penultimate exon. Taken together, these data on NMD-activating and NMD-immune mutations in COL1A1, COL6A1 and COL6A2 are consistent with the EJC-dependent model of PTC identification that predicts stop codons are recognized at premature as long as they are more than 50-55 nt upstream of the most 39 exon-exon boundary, and confirm that the EJC-dependent model developed using genes with relatively few exons also applies to genes with many small exons.
COL10A1 NMD is EJC-independent and displays tissue specificity Metaphyseal chondrodysplasia, type Schmid (MCDS; OMIM 165500) is an autosomal dominant skeletal dysplasia that is caused by missense and nonsense mutations in the collagen a1(X) chain gene COL10A1 which is expressed exclusively by hypertrophic chondrocytes during endochondral ossification (Bateman et al., 2005) . COL10A1 is unlike most other collagen genes as it has only three exons, with the third exon coding for almost the entire collagen X protein (629 of the 680 amino acids) (Thomas et al., 1991) . In addition, COL10A1 mRNA has a long 39UTR of 993 nt in mice (Apte and Olsen, 1993) and 1054 nt in humans (Thomas et al., 1991) .
Interestingly, PTC mutations in patients with MCDS have only been found in a restricted region towards the 39 end of exon 3; all of the PTCs are located between 9 and 77 codons upstream of the normal stop codon (Bateman et al., 2005) . Only three of these PTCs, W611X, Y632X and Y663X, have been studied in chondrocytes from patients and they all trigger NMD (Bateman et al., 2003; Chan et al., 1998; Ho et al., 2007) . This is surprising because the EJC-dependent PTC recognition model predicts that The mutations in COL1A1, COL6A1 and COL6A2 are less than 50-55 nt upstream of the next exon-exon junction and their degradation reinforces the applicability of the EJC model of NMD where stop codons located more than 50-55 nt upstream of the most 39 exon-exon junction are recognized as premature. The mutations in COL10A1 challenge the rule that PTCs in the last exon do not elicit NMD. EEJ, exon-exon junction. mRNAs with nonsense mutations in terminal exons are stable as they lack a downstream EJC to mark the stop codon as premature. To better understand NMD of COL10A1 transcripts with PTCs in the last exon and the observed clustering of PTC mutations in patients, we engineered PTC mutations throughout exon 3 in genomic mouse Col10a1 constructs, which were then transfected into chondrocytes (Tan et al., 2008) (Fig. 2A) . These experiments showed that Y632X, W651X and Y663X (147, 90 and 54 nt upstream of the normal stop codon, respectively) induce NMD, whereas PTCs that are located either further upstream (Y582X) or downstream (G674X) did not, thus confirming that NMD competency is restricted to a small region of the gene that is located between ,30 and ,250 nt upstream of the normal translation termination codon in exon 3 that corresponds to the region containing the known MCDS PTC mutations. Such a clustering of NMD competency into a localised region relatively close to the normal stop codon, and the failure of PTCs that are located towards the 59 end of the transcript to elicit NMD, has not been previously reported and points to PTC-recognition mechanisms not described in previous NMD models. NMD of COL10A1 does not require a downstream EJC (Fig. 2B ) and is also not consistent with the faux 39UTR or ribosome release models as PTCs located far from the poly(A) tail do not activate decay in these models (Fig. 2C,D ). An obvious candidate to specify NMD of Col10a1 is its long 39UTR. The 39UTR has three strongly conserved regions that, when deleted individually, protect Col10a1 mRNAs that possess a known NMD-competent mutation (Y632X) from degradation (Tan et al., 2008) (Fig. 2) . These data implicate the 39UTR in COL10A1 NMD and suggest that a downstream marker, such as an RNA secondary structure, protein complex or non-coding RNA, that is recruited by the 39UTR is involved in recognizing PTCs and activating NMD or in protecting normal transcripts from decay.
Because translation reinitiation downstream of the PTC can protect mutated mRNAs from NMD (Hamid et al., 2010; NeuYilik et al., 2011; Zhang and Maquat, 1997) , we searched for downstream Kozak consensus sequences that could allow translation reinitiation of PTC-containing Col10a1 transcripts. The stop codons at positions 174, 308, 407, 502, 518 and 582 that did not cause NMD (Tan et al., 2008) are all upstream of at least one Kozak translation initiation sequence, providing a theoretical explanation for why these are resistant to NMD. However, reinitiation downstream of PTCs that have escaped from NMD has only been described for mutations that are preceded by a short open reading frame of 23 or less codons (Hamid et al., 2010; Neu-Yilik et al., 2011) . In contrast, the open reading frames in Col10a1 transcripts that are resistant to NMD are much longer (between 174 and 582 codons) and, moreover, reinitiation appears unlikely based on our current understanding of the parameters that are important, such as a sufficiently short upstream open reading frame of less than about 30 codons and a sufficiently long intercistronic distance of greater than about 30 codons (Kochetov et al., 2008; Kozak, 1987; Morris and Geballe, 2000; Neu-Yilik et al., 2011) . Thus, although translation reinitiation as the underlying cause of NMD resistance in the Regions of exons that are non-coding and coding are depicted as thin and thick boxes, respectively, with introns represented by lines. The exons are drawn to scale, whereas the introns are not. NMD is elicited when PTCs occur within a specific NMD-competent region (red shading) in the terminal exon (exon 3). The codon numbers shown above the gene are the positions of PTC mutations that have been experimentally tested for NMD (Tan et al., 2008) . The region in which PTCs do not cause NMD is shaded in grey. PTCs in the region upstream of codon 174 (white) have not been experimentally tested. The three highly conserved regions within the 39UTR that abolish Col10a1 NMD when deleted individually are shown in blue and it is proposed that these function in mediating NMD of Col10a1. (B) In the EJC-dependent model, premature termination events are characterized by the presence of an EJC downstream of the PTC which functions in the recruitment of additional NMD factors. According to this model, the NMD-competent region (red shading) is located more than 55 nt upstream of the exon-2-exon-3 boundary. Crucially, the EJC-dependent model predicts that all of Col10a1 exon 3 would be immune to NMD. (C) The faux 39UTR model predicts that NMD would occur in exon 3 (red shading), when the ribosome arriving at the PTC is out-of-range of the 39UTR and PABPC1. In the closed-loop mRNA conformation, regions towards the 59 end of the mRNA will also be in range to allow eRF3 to interact with 39UTR/PABPC1, and thus this region is shown as potentially NMD incompetent (grey shading). Colour graduation from red to grey reflects the idea that the model does not predict a precise distance from either the translation start or the full-length translation stop codon where introduced stop codons would trigger NMD. (D) In the ribosome release model, NMD is proposed to involve increased exposure and susceptibility of the mRNA to degradation following early release of the ribosome, which would normally protect the transcript. This model predicts that Col10a1 NMD would occur (red shading) in all but the most 39 regions of the mRNA.
Col10a1 gene appears unlikely, it remains to be confirmed experimentally.
How does NMD of COL10A1 fit with the other current mechanistic models of NMD? According to the faux 39UTR model, the long 39UTR downstream of a PTC does not have the appropriate structure to allow interaction between eRF3 and PABP to promote a normal translation termination and result in the aberrant translation termination that allows NMD factors to bind to the ribosome and trigger NMD (Amrani et al., 2004; Amrani et al., 2006) . This model can explain why collagen PTCs near the 39 end of the terminal exon of a gene do not promote decay [e.g. COL1A1 X1428 which is located 37 codons from the normal stop (Bateman et al., 1989) ], but it does not explain why the Col10a1 PTC mutations Y632X, W651X and Y663X, which are located 18 to 49 codons upstream of the normal stop codon, result in NMD (Tan et al., 2008) (Fig. 2) . The faux 39UTR model also fails to explain why the nonsense mutations that are located towards the 59 end of Col10a1 exon 3 do not result in transcript degradation. In the EJC-dependent model, the described indicators of premature termination and NMD activation would fail to identify Y632X, W651X and Y663X as premature since no downstream introns are present and thus, neither splicing nor EJC deposition occurs. In the context of the unified model, which considers the mRNA to adopt a circular conformation, an outcome that is similar to that of the faux 39UTR model is likely to occur and all the PTCs in exon 3 should trigger NMD. With regard to the ribosome release model, a premature termination in close proximity to the normal stop codon would be expected to minimise the length of the mRNA transcript that is left exposed owing to early ribosome release and, thus, should not result in degradation of the mutant message. The ribosome release model also predicts that nonsense mutations towards the 59 end of exon 3 would lead to NMD activation (Fig. 2D) .
Another aspect of COL10A1 NMD that is unusual and does not readily fit with mechanisms that suggest a ubiquitous set of factors are involved in NMD is the tissue specificity of COL10A1 NMD (Bateman et al., 2003) . Here, our laboratory compared the decay of PTC-containing COL10A1 mRNA between hypertrophic cartilage cells (the affected tissue), bone cells and lymphoblasts from MCDS patients. We found that NMD was restricted to the cartilage cells and, furthermore, resulted in complete mRNA degradation, which is unusual as low levels of mutant mRNA commonly remain (Bateman et al., 2003) . This tissue-specificity suggests that collagen-X-producing cartilage cells contain unique factors that are necessary for this particular mRNA decay. Some degree of cell type specificity with regard to the extent of NMD has been reported previously for TCRB transcripts (Carter et al., 1996) , but such a striking 'all-or-none' cell specificity of NMD is novel (Bateman et al., 2003; Chan et al., 1998) .
Conclusions
It has become clear that the mechanistic basis for PTC recognition remains contentious and differs among organisms, even though the core NMD machinery is highly conserved from yeast to humans. Further complication arises from the variation of PTC recognition and NMD efficiency that is observed even within the same species. Studies involving members of the collagen gene family, including COL1A1, COL6A1 and COL6A2 reinforce the EJC-dependent NMD model, which suggests that mRNAs with PTC located more than 50 nt upstream of the most 39 exon-exon junction or in the last exon are not degraded.
In the case of COL10A1, the available data suggest a fundamentally different mechanism of PTC recognition achieved through the involvement of the 39UTR. Although COL10A1 NMD is specific to hypertrophic chondrocytes, other genes that possess both a long last exon and an extended 39UTR exist, and, thus, such a mechanism of mRNA surveillance could be more widespread. The involvement of the 39UTR in recognizing premature translation termination codons in genes with large terminal exons could represent a fail-safe mechanism to eliminate mutant transcripts that would otherwise escape degradation and result in dominant-negative deleterious effects. Further studies are necessary to explore the general applicability of such a 39UTR-directed process in NMD of mammalian genes with these structural characteristics.
